-+ 0.00%
-+ 0.00%
-+ 0.00%

Lixte Biotechnology Unveils Promising Study Results: LB-100 Shows Enhanced Immunotherapy Response in Ovarian and Colorectal Cancer Trials

Reuters·07/11/2025 12:45:46

Please log in to view news